Septicemia prevention and treatment system
US6193681A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Sep 14, 1998 |
| Grant date | Feb 27, 2001 |
| Priority date | — |
| Expiry date | Sep 14, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2205/75
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A method and apparatus for preventing and treating septicemia in patient blood. The extracorporeal system includes an anti-microbial device to kill at least 99% of bloodborne microorganisms, a hemoconcentrator/filtration unit to remove approximately 90% of target molecules from the patient blood and a filter unit to remove target molecules from patient blood from the sieved plasma filtrate. Target molecules are produced by microorganisms as well as the patient's cells and include endotoxins from gram negative bacteria, exotoxins from gram negative and gram positive bacteria, as well as RAP protein mediator from Staphylococcus aureus, and cell mediators such as tumor necrosis factor-alpha, and interleukin 1-beta, complement proteins C3a and C5a, and brandykinin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.